Peng, K.Safonova, Y.Mikhail ShugayPopejoy, A.B.Rodriguez, O.L.Breden, F.Brodin, P.Burkhardt, A.M.Bustamante, C.Cao-Lormeau, V-M.Corcoran, M.M.Duffy, D.Fuentes-Guajardo, M.Fujita, R.Greiff, V.Jönsson, V.D.Liu, X.Quintana-Murci, L.Rossetti, M.Xie, J.Yaari, G.Zhang, W.Abedalthagafi, M.S.Adekoya, K.O.Ahmed, R.A.Chang, W-C.Gray, C.Nakamura, Y.Lees, W.D.Khatri, P.Alachkar, H.Scheepers, C.Watson, C.T.Hedestam, G.K.Mangul, S.2024-06-072024-06-072021Peng K, Safonova Y, Shugay M, Popejoy AB, Rodriguez OL, Breden F, Brodin P, Burkhardt AM, Bustamante C, Cao-Lormeau V-M, Corcoran MM, Duffy D, Fuentes-Guajardo M, Fujita R, Greiff V, Jönsson VD, Liu X, Quintana-Murci L, Rossetti M, Xie J, Yaari G, Zhang W, Abedalthagafi MS, Adekoya KO, Ahmed RA, Chang W-C, Gray C, Nakamura Y, Lees WD, Khatri P, Alachkar H, Scheepers C, Watson CT, Karlsson Hedestam GB, Mangul S. Diversity in immunogenomics: the value and the challenge. Nature Methods. 2021;18(6):588-91. DOI: 10.1038/s41592-021-01169-5.10.1038/s41592-021-01169-5https://www.nature.com/articles/s41592-021-01169-5https://doi.org/10.1038/s41592-021-01169-5https://hdl.handle.net/11288/596241Immunogenomics studies have been largely limited to individuals of European ancestry, restricting the ability to identify variation in human adaptive immune responses across populations. Inclusion of a greater diversity of individuals in immunogenomics studies will substantially enhance our understanding of human immunology.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/ImmunogenomicsHuman adaptive immune responsesDiversitySDG-03 Good health and well-beingArticleNature Methods